Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125613631 | 12561363 | 1 | I | 20160628 | 20160708 | 20160715 | 20160715 | PER | US-CELGENEUS-USA-2016072151 | CELGENE | 65.74 | YR | F | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125613631 | 12561363 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | M9941101-08 | 20785 | 150 | MG | CAPSULES | |||||
125613631 | 12561363 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | M9941101-08 | 20785 | 150 | MG | CAPSULES |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125613631 | 12561363 | 1 | Hereditary haemorrhagic telangiectasia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125613631 | 12561363 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125613631 | 12561363 | Constipation | |
125613631 | 12561363 | Decreased appetite | |
125613631 | 12561363 | Fatigue | |
125613631 | 12561363 | Full blood count decreased | |
125613631 | 12561363 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125613631 | 12561363 | 1 | 201605 | 0 | ||
125613631 | 12561363 | 2 | 20160617 | 20160628 | 0 |